You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,335,391


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,335,391 protect, and when does it expire?

Patent 10,335,391 protects RHOFADE and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 10,335,391
Title:Stabilized oxymetazoline formulations and their uses
Abstract: The present invention provides stabilized cream formulations of oxymetazoline and uses thereof. The present invention also provides a method of treating facial erythema associated with rosacea in a patient in need of such treatment, comprising topically administering once or twice daily to the site of erythema on the face of the patient a pharmaceutical composition comprising 0.5%, 1.0% or 1.5% oxymetazoline or a pharmaceutically acceptable salt thereof as the sole active ingredient.
Inventor(s): Sarpotdar; Pramod (Rhonert Park, CA), Warner; Kevin (Anaheim, CA), Zhang; Steven (Newton, MA), Ahluwalia; Gurpreet (Tustin, CA), Kuang; Amy (Irvine, CA)
Assignee: ACLARIS THERAPEUTICS, INC. (Wayne, PA)
Application Number:15/984,918
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,335,391
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions. The U.S. Patent and Trademark Office (USPTO) is the primary agency responsible for granting these patents. This article will delve into the scope and claims of U.S. patents, using the example of U.S. Patent 10,335,391, and provide a broader context of the patent landscape in the United States.

The Role of the USPTO

The USPTO is the federal agency that grants U.S. patents and registers trademarks. It plays a crucial role in promoting innovation by protecting intellectual property rights[5].

What is a Patent?

A patent is the creation of new, useful, and nonobvious goods, services, and processes. It provides the inventor with exclusive rights to make, use, and sell the invention for a specified period, typically 20 years from the filing date of the patent application[1].

Patent Claims

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and supported by the description and drawings in the patent application. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014, including claim-level statistics and document-level statistics[3].

Scope of Patent Protection

The scope of a patent is determined by its claims. These claims outline what is considered novel and nonobvious about the invention. For example, in the case of U.S. Patent 10,335,391, the claims would specify the exact aspects of the invention that are protected.

Example: U.S. Patent 10,335,391

While the specific details of U.S. Patent 10,335,391 are not provided here, a typical patent would include:

  • Background of the Invention: An overview of the existing technology and the problems it solves.
  • Summary of the Invention: A brief description of the invention.
  • Detailed Description: A detailed explanation of the invention, including drawings and diagrams.
  • Claims: The specific aspects of the invention that are protected.

Patent Landscape in the United States

Global and Cross-National Activity

The USPTO grants patents to inventors from around the world. In 2016, the USPTO granted over 300,000 patents, with nearly half going to U.S. inventors, followed by Japan and the European Union[1].

Industry-Level Patenting

High-technology manufacturing and commercial knowledge-intensive services industries dominate the patent landscape. In 2015, U.S. high-technology manufacturing industries received 61% of the patents granted to U.S. manufacturing industries, while commercial knowledge-intensive services received 87% of the patents granted to non-manufacturing industries[1].

Technology Areas

Patent data filings include detailed information on technology areas. For instance, in 2016, more than half of the patents granted to universities were in fields such as pharmaceuticals, biotechnology, medical technology, organic fine chemistry, and measurement. Digital communications, microstructural and nanotechnology, and computer technology showed significant growth rates[1].

Trends in Patenting

Recent Increases and Changes

The number of patent infringement lawsuits has fluctuated over the years, with a significant increase in 2011 due to the anticipation of changes in the Leahy-Smith America Invents Act (AIA). This act limited the number of defendants in a lawsuit, leading to more lawsuits being filed[4].

Impact of Global Events

Global events, such as the GATT Bubble in the mid-1990s, have significantly impacted patent filings. During this period, there was a surge in patent applications as inventors sought to take advantage of changes in patent terms[2].

Challenges in Patent Litigation

Patent litigation is complex and often involves multiple defendants. From 2007 to 2011, the number of defendants in patent infringement lawsuits increased by about 129%, with software-related patents accounting for a significant portion of this increase[4].

Key Players in the Patent Landscape

Top Patent Holders

Companies like IBM, Samsung, Canon, Qualcomm, and Google are among the top recipients of USPTO patents. In 2015, these companies were among the five organizations awarding the highest numbers of patents[1].

Non-Practicing Entities (NPEs)

NPEs, also known as patent trolls, play a significant role in patent litigation. They account for about a fifth of all patent infringement lawsuits, often targeting companies that make products[4].

Economic Impact of Patents

Patents are crucial for economic growth as they encourage innovation and investment in research and development. The data from the USPTO and other sources indicate that industries with high patent activity tend to have higher R&D investments and economic output[1].

Conclusion

Patents are a vital component of the innovation ecosystem, providing inventors and companies with the protection they need to bring new ideas to market. Understanding the scope and claims of patents, as well as the broader patent landscape, is essential for navigating this complex field.

Key Takeaways

  • Patent Claims Define Scope: The claims in a patent application determine the protection granted to the invention.
  • Industry Dominance: High-technology manufacturing and commercial knowledge-intensive services dominate the patent landscape.
  • Global Influence: The USPTO grants patents to inventors worldwide, with significant contributions from the U.S., Japan, and the EU.
  • Litigation Trends: Changes in patent laws and global events impact patent litigation and filings.
  • Economic Impact: Patents are crucial for economic growth by encouraging innovation and R&D investment.

FAQs

What is the primary role of the USPTO?

The USPTO is responsible for granting U.S. patents and registering trademarks, promoting innovation by protecting intellectual property rights.

How are patent claims defined?

Patent claims are defined by the specific aspects of the invention that are novel and nonobvious, outlined in the patent application.

Which industries dominate the patent landscape in the U.S.?

High-technology manufacturing and commercial knowledge-intensive services industries receive the majority of patents granted in the U.S.

What was the impact of the GATT Bubble on patent filings?

The GATT Bubble led to a significant surge in patent applications as inventors sought to take advantage of changes in patent terms.

How have changes in patent laws affected patent litigation?

Changes, such as those introduced by the Leahy-Smith America Invents Act, have led to an increase in the number of patent infringement lawsuits by limiting the number of defendants in a single lawsuit.

Sources

  1. NSF: "Invention, Knowledge Transfer, and Innovation" - Chapter 8, NSB 2018 Report.
  2. CAFC: "HYATT v. HIRSHFELD" - Court of Appeals for the Federal Circuit.
  3. USPTO: "Patent Claims Research Dataset".
  4. GAO: "Assessing Factors That Affect Patent Infringement Litigation".
  5. USA.gov: "U.S. Patent and Trademark Office (USPTO)".

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,335,391

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma RHOFADE oxymetazoline hydrochloride CREAM;TOPICAL 208552-001 Jan 18, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ONCE DAILY TOPICAL TREATMENT OF PERSISTENT FACIAL ERYTHEMA ASSOCIATED WITH ROSACEA IN ADULTS WITH 1% OXYMETAZOLINE HYDROCHLORIDE CREAM, WHERE THE PATIENT EXPERIENCES NO REBOUND OR WORSENING OF FACIAL ERYTHEMA POST-TREATMENT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,335,391

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015274532 ⤷  Subscribe
Canada 2951725 ⤷  Subscribe
European Patent Office 3154517 ⤷  Subscribe
Spain 2796871 ⤷  Subscribe
Mexico 2016016400 ⤷  Subscribe
New Zealand 727233 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.